Simplex Trading’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.7K | Sell |
100
-1,500
| -94% | -$50.4K | ﹤0.01% | 8242 |
|
|
2025
Q4 | $68.5K | Sell |
1,600
-5,400
| -77% | -$204K | ﹤0.01% | 5364 |
|
|
2025
Q3 | $198K | Buy |
+7,000
| New | +$209K | ﹤0.01% | 4943 |
|
|
2025
Q2 | – | Sell |
-500
| Closed | -$8K | – | 9575 |
|
|
2025
Q1 | $8K | Buy |
+500
| New | +$10.1K | ﹤0.01% | 7261 |
|
|
2024
Q4 | – | Sell |
-2,300
| Closed | -$37K | – | 9447 |
|
|
2024
Q3 | $37K | Sell |
2,300
-400
| -15% | -$4.7K | ﹤0.01% | 6165 |
|
|
2024
Q2 | $22K | Buy |
+2,700
| New | +$28.3K | ﹤0.01% | 6817 |
|
|
2024
Q1 | – | Sell |
-1,170
| Closed | -$16K | – | 9706 |
|
|
2023
Q4 | $16K | Sell |
1,170
-140
| -11% | -$1.43K | ﹤0.01% | 7101 |
|
|
2023
Q3 | $14K | Sell |
1,310
-40
| -3% | -$481 | ﹤0.01% | 6942 |
|
|
2023
Q2 | $17K | Buy |
1,350
+1,220
| +938% | +$16.5K | ﹤0.01% | 6937 |
|
|
2023
Q1 | $1K | Buy |
130
+20
| +18% | +$318 | ﹤0.01% | 8757 |
|
|
2022
Q4 | $1K | Sell |
110
-10,020
| -99% | -$91.9K | ﹤0.01% | 8904 |
|
|
2022
Q3 | $119K | Sell |
10,130
-1,590
| -14% | -$21.5K | ﹤0.01% | 5279 |
|
|
2022
Q2 | $132K | Buy |
11,720
+1,450
| +14% | +$29.1K | ﹤0.01% | 5191 |
|
|
2022
Q1 | $307K | Sell |
10,270
-4,380
| -30% | -$119K | ﹤0.01% | 4521 |
|
|
2021
Q4 | $388K | Sell |
14,650
-5,950
| -29% | -$180K | ﹤0.01% | 4176 |
|
|
2021
Q3 | $927K | Hold |
20,600
| – | – | ﹤0.01% | 3178 |
|
|
2021
Q2 | $894K | Buy |
20,600
+20,424
| +11,605% | +$771K | ﹤0.01% | 3283 |
|
|
2021
Q1 | $600K | Buy |
176
+57
| +48% | +$2.26K | ﹤0.01% | 3112 |
|
|
2020
Q4 | $416K | Buy |
119
+79
| +198% | +$2.29K | ﹤0.01% | 3669 |
|
|
2020
Q3 | $96K | Buy |
+40
| New | +$982 | ﹤0.01% | 4949 |
|
|
2020
Q1 | – | Sell |
-13
| Closed | -$27K | – | 8151 |
|
|
2019
Q4 | $27K | Buy |
13
+1
| +8% | +$21 | ﹤0.01% | 5736 |
|
|
2019
Q3 | $22K | Buy |
+12
| New | +$248 | ﹤0.01% | 5750 |
|
|
2019
Q1 | – | Sell |
-30
| Closed | -$69K | – | 7732 |
|
|
2018
Q4 | $69K | Buy |
30
+10
| +50% | +$282 | ﹤0.01% | 4218 |
|
|
2018
Q3 | $64K | Buy |
+20
| New | +$600 | ﹤0.01% | 4913 |
|
|
2018
Q2 | – | Sell |
-30
| Closed | -$19K | – | 7807 |
|
|
2018
Q1 | $19K | Buy |
+30
| New | +$1.2K | ﹤0.01% | 3424 |
|
|
2017
Q3 | – | Sell |
-20
| Closed | -$3K | – | 6512 |
|
|
2017
Q2 | $3K | Buy |
20
+15
| +300% | +$411 | ﹤0.01% | 5017 |
|
|
2017
Q1 | $9K | Buy |
+5
| New | +$127 | ﹤0.01% | 4079 |
|
|
2016
Q3 | – | Sell |
-39
| Closed | -$97K | – | 6358 |
|
|
2016
Q2 | $97K | Buy |
+39
| New | +$970 | 0.01% | 1495 |
|
Other funds holding RIGL
AC
VCM
Simplex Trading's RIGL Position: Q4 2025 in Review
Simplex Trading sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 1,305 shares — an estimated $49.2K sold.
Simplex Trading first reported a position in RIGL in Q4 2014 and held it in 26 quarters. The position peaked at $323K in Q1 2021. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.
- Simplex Trading reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 1,305 Rigel Pharmaceuticals shares in Q4 2025, an estimated $49.2K.
- Simplex Trading first reported a position in Rigel Pharmaceuticals in Q4 2014 and held it in 26 quarters.
- Simplex Trading's Rigel Pharmaceuticals position peaked at $323K in Q1 2021.
- 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.